BioCentury
ARTICLE | Company News

Guilford, Aventis deal

October 30, 2000 8:00 AM UTC

GLFD reacquired from AVE worldwide distribution and marketing rights, except for Scandinavia, to GLFD's Gliadel Wafer carmustine implant for use as an adjunct to surgery to prolong survival in patien...